Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
S336934-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $454.90 | |
S336934-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $4,095.90 |
a potent and selective thromboxane A2 receptor antagonist
Synonyms | SQ 29548 | (Z)-7-((1S,2R,3R,4R)-3-((2-(Phenylcarbamoyl)hydrazineyl)methyl)-7-oxabicyclo[2.2.1]heptan-2-yl)hept-5-enoic acid | 5-Heptenoic acid, 7-((1S,2R,3R,4R)-3-((2- ((phenylamino)carbonyl)hydrazino)methyl)-7-oxabicyclo(2.2.1)hept-2-yl)-, (5Z)- | HY |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | ANTAGONIST |
Mechanism of action | Antagonist of TP receptor |
Note | Chemical can be stored as supplied for 1 year at -20° C. |
Product Description | SQ-29548 is a compound that reversibly and competitively acts as a TXA2R (thromboxane A|2|/prostraglandin endoperoxide receptor) antagonist. Ischemic studies show that SQ 29548 significantly rescues myocardial tissue and Canine postischemic cerebral hypoperfusion studies report that SQ-29548 does not help improve postischemic cerebral hypoperfusion. SQ-29548 has been shown to bind and inhibit the thromboxane A2/prostaglandin endoperoxide receptor more potently than ONO 3708, BM 13.17, and 13-APA . |
Ki Data | [3H]-U-46619 binding to human platelet membranes: Ki= 7.9 nM |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
IUPAC Name | (Z)-7-[(1S,2R,3R,4R)-3-[[2-(phenylcarbamoyl)hydrazinyl]methyl]-7-oxabicyclo[2.2.1]heptan-2-yl]hept-5-enoic acid |
---|---|
INCHI | InChI=1S/C21H29N3O4/c25-20(26)11-7-2-1-6-10-16-17(19-13-12-18(16)28-19)14-22-24-21(27)23-15-8-4-3-5-9-15/h1,3-6,8-9,16-19,22H,2,7,10-14H2,(H,25,26)(H2,23,24,27)/b6-1-/t16-,17+,18+,19-/m1/s1 |
InChi Key | RJNDVCNWVBWHLY-YVUOLYODSA-N |
Canonical SMILES | C1CC2C(C(C1O2)CC=CCCCC(=O)O)CNNC(=O)NC3=CC=CC=C3 |
Isomeric SMILES | C1C[C@@H]2[C@H]([C@H]([C@H]1O2)C/C=C\CCCC(=O)O)CNNC(=O)NC3=CC=CC=C3 |
WGK Germany | 3 |
PubChem CID | 5311448 |
Molecular Weight | 387.47 |
PubChem CID | 6437074 |
---|---|
CAS Registry No. | 98672-91-4 |
GPCRdb Ligand | SQ-29548 |
Enter Lot Number to search for COA:
Solubility | Soluble in ethanol, methanol, acetonitrile, PBS pH 7.2, DMSO, dimethyl formamide , and 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin (4.7 mg/mL). Insoluble in water. |
---|---|
Refractive Index | n20D1.58 |
Specific Rotation[α] | α22/D +19.8°, c = 1.4 in methanol(lit.) |
WGK Germany | 3 |
---|